On December 12, 2023 Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, reported that Shawn Iadonato, Ph.D., Chief Executive Officer of Kineta, will present live at the Life Science Investor Forum, hosted by VirtualInvestorConferences.com, on December 14th, 2023 (Press release, Kineta, DEC 12, 2023, View Source;utm_medium=rss&utm_campaign=kineta-to-present-at-the-life-sciences-investor-forum-december-14th [SID1234638496]). Dr. Iadonato will engage in a "CEO Chat" session with John Vandermosten, Senior Biotechnology Analyst with Zacks Small-Cap Research.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
DATE: December 14th , 2023
TIME: 11:30 A.M. Eastern
LINK: https://bit.ly/3FgGsBt
Available for 1×1 meetings: December 14th, 15th, 18th and 19th
This will be a live, interactive online event with Dr. Iadonato and John and investors will be given the opportunity to ask Dr. Iadonato and John questions at the end of the session. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.virtualinvestorconferences.com.